Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Fresenius Medical Care ADR Reptg 0.5 Ord Shs FMS

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.


NYSE:FMS - Post by User

Post by whytestockson Feb 20, 2024 10:30pm
62 Views
Post# 35890115

Fresenius Medical Care delivers on commitments in a year of

Fresenius Medical Care delivers on commitments in a year of
JUST IN: $FMS Fresenius Medical Care delivers on commitments in a year of fundamental transformationFresenius Medical Care delivers on commitments in a year of fundamental transformation PR Newswire Revenue growth of 5% in 2023 driven by favorable business development Operating income 1 growth of 15% exceeding top end of outlook range, due to business growth, FME25 s...FMS - Fresenius Medical Care delivers on commitments in a year of fundamental transformation
<< Previous
Bullboard Posts
Next >>